It may seem a distant spec on the horizon, but at some point all innovators will want to submit their potential healthcare solution for regulatory approval. What a shame it would be – for innovators, investors ánd patients – if they would need to back-track, because they missed out on some essentials early on. Why not start at the end? Familiarize yourself with what regulators may need and work back to design your procedures and strategy.

Join “Start at the end” in which Johnson & Johnson Innovation – JLABS and unlock_ (the Leiden incubator program) join forces to bring you a program with learnings that may help you smooth your regulatory approach. Jasper Renz, Sr. Director Regulatory Affairs at Vico Therapeutics B.V., will kick off by sharing his experiences on the regulatory road. After, a panel of experts will share insights and discuss the regulatory landscape from different angles.